Abstract:
Bronchoobstructive syndrome diseases remain one of the leadingcauses of hospitalization and long-term treatment in the healthcare system. Theeffectiveness of medical interventions in such conditions varies significantlydepending on the selected therapeutic regimen, the level of the medical institution, and the individual characteristics of the patients. In conditions of limited resourcesand the growing need for rationalization of treatment, it is important to compare thetechnical and cost-effectiveness of existing medical care schemes. The aim of thestudy was to carry out a comparative assessment of the effectiveness of the use of different treatment regimens for diseases with bronchoobstructive syndrome in institutions of different levels of medical care during 2019–2024. Materials andmethods. A retrospective analysis of data from patients who received treatment in medical institutions of the basic, cluster, and supracluster levels was conducted. Medical histories containing information on age, gender, employment, duration of the inpatient stage of treatment, option of concomitant therapy, level of institution,and year of observation were evaluated. Treatment effectiveness was assessed usingFarrell-effectiveness and cost-effectiveness (CE) indicators using Tobit regression models.
